The Protein Kinase C??-Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts, Cancer Research, vol.65, issue.16, pp.7462-7471, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0071
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer, Annals of Oncology, vol.21, issue.5, pp.1020-1026, 2010. ,
DOI : 10.1093/annonc/mdp521
Phase II Study of Enzastaurin, a Protein Kinase C Beta Inhibitor, in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Journal of Clinical Oncology, vol.25, issue.13, pp.1741-1747, 2007. ,
DOI : 10.1200/JCO.2006.09.3146
Interaction between protein kinase Cdependent and G protein-dependent pathways in the regulation of natural killer cell granule exocytosis, J Biol Chem, vol.267, pp.23957-62, 1992. ,
Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity, Journal of Experimental Medicine, vol.180, issue.4, pp.1427-1462, 1994. ,
DOI : 10.1084/jem.180.4.1427
Evidence that Protein Kinase C Activation is Essential for Killing by IL-2-Activated Lymphocytes, Scandinavian Journal of Immunology, vol.244, issue.1 ,
DOI : 10.1016/0167-5699(88)91201-7
Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms, FEBS Letters, vol.272, issue.3, pp.217-240, 2000. ,
DOI : 10.1016/S0014-5793(00)02162-1
Glycogen synthase kinase-3 promotes the synergistic action of interferon-?? on lipopolysaccharide-induced IL-6 production in RAW264.7 cells, Cellular Signalling, vol.21, issue.6, pp.978-85, 2009. ,
DOI : 10.1016/j.cellsig.2009.02.019
Role for Glycogen Synthase Kinase-3 in NK Cell Cytotoxicity and X-Linked Lymphoproliferative Disease, The Journal of Immunology, vol.174, issue.8, pp.4551-4559, 2005. ,
DOI : 10.4049/jimmunol.174.8.4551
Fc Receptors on Natural Killer Cells, Curr Top Microbiol Immunol, vol.230, pp.63-88, 1998. ,
DOI : 10.1007/978-3-642-46859-9_6
Activation, coactivation, and costimulation of resting human natural killer cells, Immunological Reviews, vol.137, issue.1, pp.73-91, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-4603
NK cells at the interface between innate and adaptive immunity, Cell Death and Differentiation, vol.178, issue.2, pp.226-259, 2008. ,
DOI : 10.1182/blood-2004-10-4035
Natural Killer Cell Signaling Pathways, Science, vol.306, issue.5701, pp.1517-1526, 2004. ,
DOI : 10.1126/science.1103478
URL : https://hal.archives-ouvertes.fr/hal-00080580
Natural killer cell receptor signaling, Current Opinion in Immunology, vol.15, issue.3, pp.308-322, 2003. ,
DOI : 10.1016/S0952-7915(03)00039-6
NKG2D- mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and ,
NKG2D-DAP10 triggers human NK cell???mediated killing via a Syk-independent regulatory pathway, Nature Immunology, vol.4, issue.6, pp.557-64, 2003. ,
DOI : 10.1038/ni929
Vav1 Controls DAP10-Mediated Natural Cytotoxicity by Regulating Actin and Microtubule Dynamics, The Journal of Immunology, vol.177, issue.4, pp.2349-55, 2006. ,
DOI : 10.4049/jimmunol.177.4.2349
NK cell-activating receptors require PKC-?? for sustained signaling, transcriptional activation, and IFN-?? secretion, Blood, vol.112, issue.10, pp.4109-4125, 2008. ,
DOI : 10.1182/blood-2008-02-139527
Multiplicity and plasticity of natural killer cell signaling pathways, Blood, vol.107, issue.6, pp.2364-72, 2006. ,
DOI : 10.1182/blood-2005-08-3504
URL : https://hal.archives-ouvertes.fr/hal-00080580
Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells, Nature Immunology, vol.1, issue.5, pp.419-444, 2000. ,
DOI : 10.1038/80859
Syk Regulation of Phosphoinositide 3-Kinase-Dependent NK Cell Function, The Journal of Immunology, vol.168, issue.7, pp.3155-64, 2002. ,
DOI : 10.4049/jimmunol.168.7.3155
Phospholipase C-??2 Is a Critical Signaling Mediator for Murine NK Cell Activating Receptors, The Journal of Immunology, vol.175, issue.2, pp.749-54, 2005. ,
DOI : 10.4049/jimmunol.175.2.749
Phospholipase C-??2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells, Blood, vol.107, issue.3, pp.994-1002, 2006. ,
DOI : 10.1182/blood-2005-06-2428
Differential and Nonredundant Roles of Phospholipase C??2 and Phospholipase C??1 in the Terminal Maturation of NK Cells, The Journal of Immunology, vol.177, issue.8, pp.5365-76, 2006. ,
DOI : 10.4049/jimmunol.177.8.5365
The Isoforms of Phospholipase C-?? Are Differentially Used by Distinct Human NK Activating Receptors, The Journal of Immunology, vol.175, issue.1, pp.213-221, 2005. ,
DOI : 10.4049/jimmunol.175.1.213
Differential Requirements for Vav Proteins in DAP10- and ITAM-mediated NK Cell Cytotoxicity, The Journal of Experimental Medicine, vol.162, issue.6, pp.817-840, 2004. ,
DOI : 10.1038/ni930
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases, J Immunol, vol.161, pp.6648-56, 1998. ,
Up on the tightrope: natural killer cell activation and inhibition, Nature Immunology, vol.179, issue.5, pp.495-502, 2008. ,
DOI : 10.1371/journal.pone.0000326
Protein Kinase C-?? Is Required for NK Cell Activation and In Vivo Control of Tumor Progression, The Journal of Immunology, vol.182, issue.4, pp.1972-81, 2009. ,
DOI : 10.4049/jimmunol.0801820
Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event, J Immunol, vol.141, pp.3164-3173, 1988. ,
Natural killer cells from protein kinase C ??-/- mice stimulated with interleukin-12 are deficient in production of interferon-??, Journal of Leukocyte Biology, vol.83, issue.5, pp.1267-76, 2008. ,
DOI : 10.1189/jlb.1107745
Protein Kinase C (PKC) ??II Induces Cell Invasion through a Ras/Mek-, PKC??/Rac 1-dependent Signaling Pathway, Journal of Biological Chemistry, vol.279, issue.21, pp.22118-22141, 2004. ,
DOI : 10.1074/jbc.M400774200
Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase C?? in endothelial cells, Cellular Signalling, vol.16, issue.8, pp.951-958, 2004. ,
DOI : 10.1016/j.cellsig.2004.01.008
PKC-?? mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways, Oncogene, vol.23, issue.56, pp.9062-9071, 2004. ,
DOI : 10.1038/sj.onc.1208093
Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation ,
Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes, J Biol Chem, vol.267, pp.16878-82, 1992. ,
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B, Nature, vol.270, issue.6559, pp.785-794, 1995. ,
DOI : 10.1038/378785a0
Convergence of Multiple Signaling Cascades at Glycogen Synthase Kinase 3: Edg Receptor-Mediated Phosphorylation and Inactivation by Lysophosphatidic Acid through a Protein Kinase C-Dependent Intracellular Pathway, Molecular and Cellular Biology, vol.22, issue.7, pp.2099-110, 2002. ,
DOI : 10.1128/MCB.22.7.2099-2110.2002
Enzastaurin, a Protein Kinase C?? Selective Inhibitor, and Its Potential Application as an Anticancer Agent in Lung Cancer, Clinical Cancer Research, vol.13, issue.15, pp.4641-4647, 2007. ,
DOI : 10.1158/1078-0432.CCR-07-0538
Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl), Blood, vol.109, issue.4, pp.1669-77, 2007. ,
DOI : 10.1182/blood-2006-08-042747
PKC?? is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKC?? as a therapeutic target in chronic lymphocytic leukemia, Blood, vol.113, issue.12, pp.2791-2795, 2009. ,
DOI : 10.1182/blood-2008-06-160713
The glamour and gloom of glycogen synthase kinase-3, Trends in Biochemical Sciences, vol.29, issue.2, pp.95-102, 2004. ,
DOI : 10.1016/j.tibs.2003.12.004
Impact of PKC?? on estrogen receptor localization and activity in breast cancer cells, Oncogene, vol.47, issue.31, pp.4946-55, 2005. ,
DOI : 10.1016/S0014-5793(00)01234-5
T cell antigen receptor dependent signalling in human lymphocytes: cholera toxin inhibits interleukin-2 receptor expression but not interleukin-2 synthesis by preventing activation of a protein kinase C isotype, PKC-??, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1356, issue.2 ,
DOI : 10.1016/S0167-4889(96)00174-7
The ?? Isoform of Protein Kinase C Controls Interleukin-2-Mediated Proliferation in a Murine T Cell Line: Evidence for an Additional Role of Protein Kinase C ?? and ??, Experimental Cell Research, vol.218, issue.1, pp.105-118, 1995. ,
DOI : 10.1006/excr.1995.1136
Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR, J Immunol, vol.160, pp.2207-2221, 1998. ,
Inhibition of the calpain-mediated proteolysis of protein kinase C enhances lytic activity in human NK cells, Cellular Immunology, vol.138, issue.1, pp.24-34, 1991. ,
DOI : 10.1016/0008-8749(91)90129-Y
Signal Transduction in Cytotoxic Lymphocytes: Decreased Calcium influx in NK Cell inactivated with Sensitive Target Cells, Cellular Immunology, vol.147, issue.2, pp.294-301, 1993. ,
DOI : 10.1006/cimm.1993.1070
Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells, Cellular Signalling, vol.21, issue.1, pp.79-86, 2009. ,
DOI : 10.1016/j.cellsig.2008.09.010
Anti-cancer activity and mechanistic features of a NK cell activating molecule, Cancer Immunology, Immunotherapy, vol.105, issue.Pt 2, pp.1691-1700, 2009. ,
DOI : 10.1007/s00262-009-0680-0